P159 Cerebrovascular status and Type 1 diabetes durationID Wilkinson1, F Fang2, M Greig1, L HUNT1, S Pallai3, S Tesfaye4, D Selvarajah31Academic Radiology, University of Sheffield, Sheffield, UK, 2Endocrinology, Shanghai JiaoTong University, Shanghai, China, 3Oncology and Metabolism, University of Sheffield, Sheffield, UK, 4Diabetes, Sheffield Teaching Hospitals, Sheffield, UKObjectives: Cerebral small vessel disease (SVD) is a complication in Type 1 diabetes. Magnetic resonance imaging (MRI) can monitor the presence and consequences of SVD. This study investigates internal carotid artery (ICA), flow resistivity index (RI) and standard imaging appearances as a function of Type 1 diabetes duration.Methods: Sixty‐six subjects (49 Type 1 diabetes and 17 healthy volunteers, HVs) with no history of cardiovascular disease/stroke were assessed and grouped by diabetes duration [short ≤15 years, medium = 15 to 30 years; long ≥30 years]. Lacunes, white matter hyperintensities (WMH) and atrophy were rated on T2‐weighted MRI. Quantitative magnetic resonance angiography assessed carotid RI.Results: There were significant differences in group mean ICA RI (HV = 0.54 ± 0.05, short = 0.56 ± 0.08, medium = 0.63 ± 0.06, long term = 0.65 ± 0.06; p < 0.001). Post hoc analysis indicated higher RI in long‐ and medium‐term compared with both short‐term (p < 0.005; p < 0.05) and HV (p < 0.001; p < 0.001) groups. There were no significant group differences in the prevalence of imaging abnormalities (χ2 = 7.064, p > 0.05). In cases of no imaging
Diabetic Medicine – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera